Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E‑deficient miceXianjing Wei, Xiaoqing Wang|Experimental and Therapeutic Medicine|2021Cited by 24